Iterum Therapeutics
Stock Forecast, Prediction & Price Target
Iterum Therapeutics Financial Estimates
Iterum Therapeutics Revenue Estimates
Iterum Therapeutics EBITDA Estimates
Iterum Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $12.13M Low: $1.72M High: $22.53M avg. 0% | Avg: $26.15M Low: $3.72M High: $48.58M avg. 115.60% | Avg: $44.63M Low: $6.35M High: $82.91M avg. 70.66% | Avg: $69.37M Low: $9.88M High: $128.86M avg. 55.41% |
Net Income
% change YoY
| $-91.56M N/A | $-44.43M 51.47% | $-38.37M 13.64% | Avg: $-18.46M Low: $-16.85M High: $-9.46M avg. 51.86% | Avg: $-12.39M Low: $-12.70M High: $-4.79M avg. 32.87% | Avg: $-4.73M Low: $-10.00M High: $543.40K avg. 61.83% | Avg: $4.40M Low: $-506.18K High: $9.32M avg. 193.15% |
EBITDA
% change YoY
| $-24.34M N/A | $-35.84M -47.23% | $-34.58M 3.51% | Avg: $7.27M Low: $1.03M High: $13.52M avg. 121.04% | Avg: $15.69M Low: $2.23M High: $29.15M avg. 115.60% | Avg: $26.78M Low: $3.81M High: $49.75M avg. 70.66% | Avg: $41.62M Low: $5.92M High: $77.32M avg. 55.41% |
EPS
% change YoY
| -$0.56 N/A | -$3.63 -548.21% | -$2.96 18.45% | Avg: -$1.02 Low: -$1.3 High: -$0.73 avg. 65.70% | Avg: -$0.68 Low: -$0.98 High: -$0.37 avg. 33.49% | Avg: -$0.37 Low: -$0.77 High: $0.04 avg. 45.92% | Avg: $0.34 Low: -$0.04 High: $0.72 avg. 193.15% |
Operating Expenses
% change YoY
| $24.53M N/A | $30.38M 23.82% | $47.46M 56.23% | Avg: $749.63M Low: $106.76M High: $1.39B avg. 1479.23% | Avg: $1.61B Low: $230.18M High: $3.00B avg. 115.60% | Avg: $2.75B Low: $392.83M High: $5.12B avg. 70.66% | Avg: $4.28B Low: $610.54M High: $7.96B avg. 55.41% |
FAQ
What is Iterum Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 84.93% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -16.85M, average is -18.46M and high is -9.46M.
What is Iterum Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 60.42% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $1.72M, average is $12.13M and high is $22.53M.
What is Iterum Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 84.57% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.3, average is -$1.02 and high is $-0.73.